A device containing living cells that mimic the structural and physiological conditions of the blood-retinal barrier has been developed by...
Read moreDetailsYour website’s page title and description can have a big effect on your SEO. That’s why it’s important to learn...
Read moreDetailsRest on your laurels and it won’t be long until you’re lagging behind your colleagues. This applies equally to both...
Read moreDetailsA highlight of this year’s Southern Regional Congress (SRC) was the H Barry Collin Medal Lecture by world-renowned microbiologist and...
Read moreDetailsThe recent School of Optometry and Vision Science (SOVS) educational alumni evening focused on presentations and related research made by...
Read moreDetailsPharmaceutical multinational Allergan will lay off more than 1,000 jobs in an effort to cut costs in anticipation of increased...
Read moreDetailsLuxottica has made major changes to its governance structure, replacing former CEO Mr Massimo Vian with deputy chairman Mr Francesco...
Read moreDetailsSwiss-based biotech company Oculis has received US$20.3 million (AU$25.5 m) in series B funding for ongoing trials of eye drops...
Read moreDetailsUS medical laser firm Iridex has launched legal action against France-based Quantel over the use of its MicroPulse laser technology,...
Read moreDetailsIt’s been announced a recently approved revolutionary gene therapy drug aimed at treating a rare type of inherited retinal dystrophy...
Read moreDetailsInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited